Literature DB >> 4066796

Regulation of cell growth by vitreous humour.

G A Lutty, R J Mello, C Chandler, C Fait, A Bennett, A Patz.   

Abstract

Extracts of normal vitreous have been found to inhibit angiogenesis in two animal models: tumour-induced neovascularization in the rabbit corneal micropocket and retinal extract-induced angiogenesis in the chick chorioallantoic membrane assay. Using in vitro assays, we have found recently that an extract of bovine vitreous, free of hyaluronic acid, inhibits proliferation of cells in the aortic wall, i.e. endothelium and smooth muscle cells, as well as capillary and corneal endothelium. The inhibition is dose-dependent, as determined by either cell count or [3H]thymidine incorporation, and not due to cytotoxicity, as demonstrated with a double-label thymidine assay. The inhibitor is trypsin-sensitive and heat-stable (95 degrees C for 10 min). Conversely, proliferation of pericytes, lens epithelium and fibroblasts (dermal and corneal) was stimulated by the vitreous extract. This mitogenic activity was heat-labile. Growth of pigment epithelium and several tumour cell lines was unaffected. The data demonstrate that normal vitreous contains a heat-stable growth inhibitor specific for endothelium and smooth muscle cells, and a non-specific heat-labile mitogen. The paradoxical effect of this antiangiogenic factor on arterial and capillary contractile cells, smooth muscle and pericytes, suggests a basic difference in the regulation of the two vasculatures. The results suggest that a substance in normal vitreous may be important in controlling neovascularization that results from diabetic and other retinopathies, and could be useful for inhibiting tumour-induced angiogenesis.

Entities:  

Mesh:

Year:  1985        PMID: 4066796     DOI: 10.1242/jcs.76.1.53

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  Partial characterization of a putative new growth factor present in pathological human vitreous.

Authors:  C Pombo; L Bokser; X Casabiell; J Zugaza; M Capeans; M Salorio; F Casanueva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

2.  Targeting Neovascularization in Ischemic Retinopathy: Recent Advances.

Authors:  Mohamed Al-Shabrawey; Mohamed Elsherbiny; Julian Nussbaum; Amira Othman; Sylvia Megyerdi; Amany Tawfik
Journal:  Expert Rev Ophthalmol       Date:  2013-06

3.  Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.

Authors:  G Gao; C Shao; S X Zhang; A Dudley; J Fant; J-X Ma
Journal:  Diabetologia       Date:  2003-05-13       Impact factor: 10.122

4.  Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-beta type 1.

Authors:  S Magyar-Lehmann; P Böhlen
Journal:  Experientia       Date:  1992-04-15

5.  Tenomodulin inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.

Authors:  Wei Wang; Zhongqiu Li; Tatsuhiko Sato; Yusuke Oshima
Journal:  Int J Mol Sci       Date:  2012-11-20       Impact factor: 5.923

6.  Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy.

Authors:  Carlos D Nuñez-Amaro; Aura Ileana Moreno-Vega; Elva Adan-Castro; Magdalena Zamora; Renata Garcia-Franco; Paulina Ramirez-Neria; Marlon Garcia-Roa; Yolanda Villalpando; Juan Pablo Robles; Gabriela Ramirez-Hernandez; Mariana Lopez; Jorge Sanchez; Ellery Lopez-Star; Thomas Bertsch; Gonzalo Martinez de la Escalera; Ma Ludivina Robles-Osorio; Jakob Triebel; Carmen Clapp
Journal:  Transl Vis Sci Technol       Date:  2020-08-17       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.